Skip to main content
Download PDF

Impact of legumes and plant proteins consumption on cognitive performances in the elderly

Journal of Translational Medicine volume 15, Article number: 109 (2017) Cite this article

Abstract

Background

Numerous studies have investigated the role of the dietary factors in the prevention of cognitive decline but the short-term effects of foods choice on cognitive performances in the elderly are poorly explored. Our aim was to investigate the choice of foods among elderly Italian individuals and the association with cognitive function.

Methods

In this longitudinal study, the participants were 214 individuals aged ≥65 years with a score >20 at the Mini Mental State Examination. The cognitive sub-test of ADAScale was used to detect cognitive decline progression over 12 months. Food choices was measured by a combination of a 24-h recall and a seven-day diet record and Principal Components Analysis.

Results

The Principal Components Analysis identified four food and four nutrient patterns. MMSE and ADAS-cog score after 1 year were found to be associated with legumes pattern (B = 0.25, p = 0.007; 95% CI 0.07/0.44; and B = −0.10, p = 0.006; CI −0.79/−0.30, respectively). A dietary pattern including plant proteins was independently associated with an improved ADAS-cog after 1 year (B = 0.584, p = 0.04; OR 1.79, CI 0.04–0.42).

Conclusions

The Principal Components Analysis is useful to investigate the choice of foods and nutrients in the elderly. We demonstrated an association between legumes pattern with cognitive performances.

Background

Cognitive decline is a complex process that is affected by both genetic and environmental factors. Research over the past fifteen years have provided strong evidence for the influence of dietary factors on specific mechanisms that maintain mental function [1,2,3,4,5]. In this regard, it is well known that a high adherence to a Mediterranean diet (MeDi) is associated with a reduced risk of developing cardiovascular risk factors which, in turn, may be associated with the development of cognitive impairments [2, 3]. Intake of fish and vegetables and nutrients such as vitamins and minerals since a young age or adulthood may lower the risk of cognitive impairment [6]. However, there is still considerable scientific uncertainty about the relationship between a healthy diet and the risk of Dementia [7]. Furthermore, the short-term effects of foods choice in the elderly are poorly explored. Eating can be difficult for elderly because of the numerous changes that occur with age and eventual presence of diseases [8]. Elderly patients also present with sensory losses due to age which may be responsible for a lack of interest in several foods [8]. Thus, we performed a study with the aim to analyse the choices and consumption of foods among elderly Italian individuals and to investigated the association between their dietary patterns and cognitive function.

Methods

This is a longitudinal study conducted from February 2013 to December 2014, whose protocol was approved by the local ethics committee at the “Mater Domini” University Hospital in Catanzaro, Italy (Projects Codes 2011.48).

A total of 214 community-dwelling, white individuals aged ≥65 years underwent a neuropsychological assessment conducted by expert neurologists using a medical assessment and two neuropsychological tests, which were the following: the Mini Mental State Examination (MMSE) and the Alzheimer’s Disease Assessment Scale-Cognitive sub-scale (ADAS-cog) [9,10,11,12,13,14,15,16].

The participants were from a Mediterranean area (Calabria region, southern Italy) and, as in other investigations of the elderly, were invited to participate in the study by newspapers advertisements [17, 18]. All subjects had an MMSE score greater than 20 [10,11,12,13], were literate and were not suffering from any debilitating diseases (like stage 2–5 chronic kidney disease, end stage liver failure, cancer, congestive heart failure). They had no previous history of cardiovascular disease (CVD) or thyroid dysfunction or excessive alcohol consumption and did not take any dietary supplements, psychotropic drugs as ascertained from their medical history, a physical and neurological examination and laboratory tests.

Since it has been already demonstrated that the ADAS-Cog can be the main outcome measure also in cognitively normal individuals [9], we performed a longitudinal evaluation lasting 12 months with the ADAS-Cog as the main outcome. This part of the study involved only a sample consisting of the first 144 subjects who had complete data on ADAS-Cog scores at the follow-up visit.

Neuropsychological assessment

The neuropsychological assessment was conducted by a medical assessment alongside the use of the MMSE and ADAS-cog.

MMSE is a global test of cognitive function with components of orientation, attention, calculation, language and recall [10]. A score of 20 or below is indicative of cognitive impairment [11, 12]. A validated Italian version was used [14].

The ADAS-cog is a psychometric scale, measuring memory disturbances, language, praxis, attention and other cognitive abilities [15]. The range of scores is from 0 to 70 and the scale of the ADAS-cog is reversed, where 0 represents no errors and 70 represents errors on all items [15, 16].

To reduce the potential for practice effects during subsequent visits, different word lists in the neuropsychological tests were used. In addition, the investigators performing the cognitive tests were blinded to the patients’ clinical data and nutrient intake.

In all patients we assessed the presence of the known classical cardiovascular (CV) risk factors and anthropometric characteristics. The following criteria were used to define the distinct CV risk factors: diabetes: fasting blood glucose ≥126 mg/dL or antidiabetic treatment; hyperlipidemia: total cholesterol >200 mg/dL and/or triglycerides >200 mg/dL or lipid lowering drugs use; hypertension: systolic blood pressure ≥130 mmHg and/or diastolic blood pressure ≥85 mmHg or antihypertensive treatment; overweight: 25 kg/m2 ≤ BMI < 30 kg/m2; obesity: body mass index (BMI) ≥30 kg/m2; smoking: current smoker: who has smoked more than 100 cigarettes in their lifetime and smoke cigarettes every day or some days [19, 20]. Written informed consent was obtained from participants. The investigation conforms to the principles outlined in the Declaration of Helsinki [21].

Dietary intake assessment

Dietary intake data were assessed by a 24-h recall and a seven-day diet record and calculated using nutritional software MetaDieta 3.0.1 (Metedasrl, San Benedetto del Tronto, Italy). The 24-h recall was collected via an interview by a dietitian who used images associated with a comprehensive food list in the program. All participants were also given a food diary, measuring sheet with life-size images of a spoon, cup and bottle sizes for food diaries. The INRAN (National Institute of Food Research) 2000 and IEO (European Institute of Oncology) 2008 database serves as the source of food composition information in the program [22]. We focused on major food groups, like consumption of fruits fresh and dry, virgin olive oil, legumes, fish, cereals, red meat, animal fats/margarines and cake/pies. The resulting database was exported into SPSS for analysis [23, 24].

Blood pressure measurement

The measurement of the systemic blood pressure (systolic blood pressure—SBP and diastolic blood pressure—DBP) of both arms was obtained by auscultatory blood pressure technique with aneroid sphygmomanometer. Clinic BP was obtained in supine patients, after 5 min of quiet rest as previously described [25].

Biochemical evaluation

Venous blood was collected after fasting overnight into vacutainer tubes (Becton & Dickinson, Plymouth, England) and centrifuged within 4 h. Serum glucose, total cholesterol, high density lipoprotein (HDL)-cholesterol, triglycerides and creatinine were measured with Enzymatic colorimetric test. Low-density lipoprotein (LDL) cholesterol level was calculated by the Friedewald formula [26]. Quality control was assessed daily for all determinations.

Anthropometric measurements

All tests were performed after a 12 h overnight fast. Body weight was measured before breakfast with the subjects lightly dressed, subtracting the weight of clothes. Body weight was measured with a calibrated scale and height measured with a wall-mounted stadiometer. BMI was calculated with the following equation: weight (kg)/height (m)2. Waist circumferences and hip circumferences (WC and HC) were measured with a nonstretchable tape over the unclothed abdomen at the narrowest point between costal margin and iliac crest and over light clothing at the level of the widest diameter around the buttocks, respectively, as described in the past [27].

12 months follow-up

Dietary guidance was provided to all enrolled patients to promote a “healthy diet” by an experienced dietitian, not including a total energy reduction or weight loss goals, nor was physical activity promoted for the entire duration of the study. The enrolled patients were contacted again after 6 months by way of telephone, reminding them to maintain their dietary pattern. In those with nutrient deficiencies or severe obesity, additional assistance was provided so as to achieve their correct nutrient intake. However, these were excluded from the follow-up study.

Data analysis

Data are reported as mean ± SD. To find a correlation between ADAS-cog (basal and follow-up) and a specific food or dietary pattern with an r equal to 0.15–0.20 and 80% power on a two-sided level of significance of 0.05, 190 subjects are required. Changes in MMSE and ADAS cog score from baseline to follow-up were compared using paired Student’s t test (two tailed).Significant differences were assumed to be present at p < 0.05 (two-tailed). All comparisons were performed using SPSS 17.0 for Windows (IBM Corporation, New York, NY, USA).

Food pattern analysis

We obtained food patterns by using the Principal Components Analysis (PCA) [28]. We also obtained, for the first time, “nutrient patterns”, using macronutrients and micronutrients as variables in place of foods groups. The food/nutrient variables were correlated together (correlation coefficients r > 0.4). The orthogonal rotation (obtained with varimax option) was used to derive food patterns (non correlated components). To fix the number of components to retain, the two screen plots of the eigenvalues, that derived from the correlation matrix of the standardized variables, were examined. The eigenvalue is a value that indicates the proportion of the variance in consumption explained by each component. According to the Kaiser criterion, the number of components that should be retained from principal components analysis is equal to the number of eigenvalues that are greater than one. The food/nutrients patterns were named according to scores of the foods/nutrients that correlated most with the factor (>0.4). A higher absolute values in the correlation coefficients indicated that the food/nutrient variable contributes most to the construction of the component. Participants were globally grouped into four different classes according to food patterns and four different according to nutrient patterns (components). The Pearson’s correlation was performed to identify the variables which correlated with the patterns above cited. We analyzed the correlation with the following variables: MMSE (basal and at follow-up), ADAS-cog (basal and at follow-up), age, education level, BMI, WC, glucose, LDL, HDL, triglycerides, SBP, DBP. Furthermore, a stepwise multivariable linear regression analysis was used to test the association between MMSE and ADAS-cog (after 1 year) and each dietary pattern, if this last was in correlation with these neuropsychological tests in the univariate analysis. Finally, we performed a logistic regression analysis to assess which pattern was correlated with an improvement on ADAS-cog test after 1 year.

Results

Baseline characteristics and factors associated with MMSE and ADAS-cog score

Table 1 shows the characteristics of the study population. The mean age was 70 ± 4 years, the MMSE score was 24 ± 1 and ADAS-cog was 16 ± 7. The participants’ nutritional intake and food groups used in the PCA are showed in Table 2. Globally, plant-based protein sources represented 37.5% of the total protein consumed.

Table 1 Demographic and clinical characteristics of the whole population
Full size table
Table 2 Characteristics of the whole population: nutrient and food groups assessment
Full size table

Changes in ADAS-cog after 1 year and food patterns analysis

MMSE and ADAS-cog scores improved at the second time point (MMSE: from 24.4 ± 1 to 25.6 ± 1, p < 0.001; ADAS-cog: from 15.4 ± 5 to 13.1 ± 5, p < 0.001). Total loss at follow-up were 70 individuals, of whom 59 failed to attend to visit, 1 died, and 20 were untraceable.

Figures 1 and 2 shows the screen plot of the eigenvalues, indicating the number of components (food and nutrients patterns) obtained. In our investigation, a four-(component) food patterns, namely: (1) cereals/meat/fish/olive oil pattern, (2) cakes/fruit pattern, (3) animal fats/margarines pattern and (4) legumes pattern; solution was selected. In addition, four-nutrient patterns, namely: (1) animal protein pattern, (2) vegetal oils pattern; (3) fats pattern and (4) plant proteins/polyunsaturated fats pattern, were identified. The correlation coefficients indicated that the food or nutrient variable contributes most to the construction of the component. To simplify this presentation, only the significant data are here shown, i.e. the only patterns associated with MMSE and/or ADAS-cog score and/or improvement on ADAS-cog, that were the following:

Fig. 1
figure1

Screen plot of the eigenvalues—number of components (food patterns)

Full size image
Fig. 2
figure2

Screen plot of the eigenvalues—number of components (nutrient patterns)

Full size image

As food patterns: (1) legumes pattern (explained variation 66%; 26 g/day = 3 serving/week); (2) animal fats/margarines pattern;

As nutrients patterns: (1) plant protein/polyunsaturated fats (variation 79%); (2) fats pattern. Table 3 shown the factors which were correlated with these patterns. In particular, legumes pattern was correlated with MMSE and ADAS-cog at basal and after 1 years (with 12-months ADAS-cog: r = −0.12 and p = 0.06; with 12-months MMSE: r = 0.21 and p = 0.01) and plant protein/polyunsaturated fats with an improved ADAS-cog test after 1 years(r = 0.18 and p = 0.03). In the stepwise multivariable linear regression analysis (Table 4), legumes pattern was found to be associated with the both ADAS-cog and MMSE after 1 year (B = −0.10, p = 0.006; 95% CI −1.79/−0.30 and B = 0.23, p = 0.01; 95% CI 0.04/0.42, respectively). Finally, vegetal proteins/polyunsatured fats pattern was found to be associated with the improved ADAS-cog (categorical variable) after 1 years (B = 0.584, p = 0.04; OR 1.79, CI 0.04–0.42, Table 5) (improved individuals were all those with a reduction of the ADAS-cog score after 1 years; not improved were those with unchanged or increased score).

Table 3 Univariate analyses—factors correlated with food (component 3 and 4) and nutrient (component 3 and 4) patterns
Full size table
Table 4 Multivariable linear regression analysis—factors associated with MMSE and ADAS-Cog after 1 year
Full size table
Table 5 Logistic regression analysis—factors associated with the improved ADAS-Cog
Full size table

Discussion

In this study we analyse the consumption of foods among elderly Italian individuals using a combination of the dietary intake data, assessed by a 24-h recall and a seven-day diet record, and the PCA to obtain, for the first time, food and nutrient patterns.

In our investigation, four food patterns and four nutrient patterns were identified. However, only two food patterns (legumes and animal fats/margarines patterns) and two nutrient patterns (plant protein/polyunsaturated fats and fats patterns) were associated with the cognitive decline tests.

Furthermore, we found a positive association between a high legumes pattern and the improved MMSE after an interval of 1 year, and an inverse association with basal and 1 year ADAS-cog test. Finally, we found that a dietary pattern that includes plant proteins and polyunsaturated fats is independently associated with an improvement on ADAS-cog after 1 year.

The choice of different foods in elderly have a relevant impact on health. Our results would support the benefit to choose a diet including legumes and plant-based proteins in elderly for preventing cognitive decline. Several previous studies have already demonstrated the beneficial effect of increased MeDi adherence or of individual components of the MeDi on cognitive function, which also belong to other food patterns [1, 6, 7], but there are also negative findings [8]. In addition, no studies have yet found the specific association between a high legumes and high plant-based proteins patterns assessed by PCA with cognitive performance assessed by ADAS-cog.

Several research have provided evidence of diet-induced changes in cerebral aminoacids and, consequently, in neurotransmitters [29,30,31,32,33]. In particular, it has been suggested that tryptophan from animal sources seems less available to synthesized neurotransmitters than those from plant sources, due to a stronger competition with other amino acids [34]. In addition, a relationship between an altered tryptophan metabolism and a high intake of red meat has been identified [35] and the inverse association between processed meat consumption and AD biomarkers has already been established in older individuals [36, 37]. Nevertheless our study was not designed to investigate the mechanisms underlying the association between legumes and cognitive function, all these studies alongside our results, may suggest a greater effect of plant-based proteins on cognitive performance than that of animal protein. Our study also suggests that a dietary pattern including polyunsatured fats may have a positive action on cognitive functions. Thus, in line with other authors [38, 39] we assume that plant-derived foods may prevent cognitive decline. Unlike other studies [38, 39], our investigation highlight the role of both legumes and plant proteins as independent predictors of cognitive performance in the elderly.

Alternatively, other mechanisms could be assumed. Legumes and vegetal oils could improve insulin sensitivity [40], which could, in turn, influence cognitive function. It has been demonstrated that an oral aminoacids mixture significantly improves insulin sensitivity in elderly subjects with sarcopenia or type 2 diabetes, probably by an up-regulation of the insulin-receptor synthesis and its autophosphorylation [41, 42]. Insulin activity could, therefore, be enhanced by legumes and vegetal oils consumption.

However, independently from the underlying mechanisms, our study can be considered relevant as it may reveal a new approach to preventing of the cognitive decline. Our participants in the high legumes pattern consumed more than three serving of legumes per week. Thus, our study should encourage the elderly to increase their weekly legumes intake. Our results are plausible as confirmed by other investigations on this topic. Epidemiologic studies suggest a positive association between flavonoid intake and better cognitive performance in elderly [4]. It has been reported that the cluster “high fish-fruit-vegetable” was associated with a better cognitive function, whereas cluster “moderate ready meals” was associated with cognitive decline of home-living older adults [43]. There is evidence that a nut consumption for 6 months can have positive effects on some cognitive functions of older adults with mild cognitive impairment [44].

Food choices as measured by the combination of a 24-h recall and a seven-day diet record using a specific nutritional software and the PCA were shown to be valid and reproducible [22, 24, 28]. These methods seems to be able to identify individuals with specific preferences but we cannot assess whether there are specific individual characteristics that determine these individual food preferences.

In our investigation we enrolled individuals with a slightly reduced MMSE score (mean 24 ± 1). Nevertheless numerous studies have suggested that the MMSE could differentiate individuals with mild cognitive impairment from those who are normal or have dementia [11, 12], other investigations have suggested that the MMSE lacks the diagnostic accuracy to differentiate between these categories [45]. Consequently, we cannot classify our population neither as with mild cognitive impairment nor as cognitively normal. Aside from that classification, with this investigation we simply generate a new hypothesis for future research and highlight the possible key role of plant proteins in the brain, which remains to be elucidated.

In addition, in our longitudinal observation, only the ADAS-Cog was the main outcome measure. This is not a novelty. In a study performed in elderly persons with normal cognition, the ADAS-Cog was already used as the only test to demonstrate the change in cognitive function overtime [10]. This investigation showed that it is possible to predict decline in cognitively normal individuals [10]. Furthermore, there is consensus that ADAS-cog is a commonly used objective measure of cognitive change in the follow-up evaluation of cognitively impaired individuals [46] and it is able to assess the clinical effects of treatment overtime [18, 47]. Conversely, there is some uncertainty regarding MMSE’s ability to document clinically important change in individual patients over time [48].

In our study, we demonstrated a significant change on ADAS-cog test after 1 year (from 15.4 ± 5 to 13.1 ± 5, p < 0.001). We categorised the population according to the improvement on ADAS-cog after 1 years (i.e. any score reduction; Table 5). At present, a cut-off point on the ADAS cog that accurately classifies patients in respect of their clinical response is not universally accepted, especially with dietary intervention. However, caution must be exercised when interpreting our results on the basis of ADAS-cog change.

In this investigation some weaknesses must be pointed out. Probably MMSE and ADAS-cog may be not ideal for healthy individuals, but these results may suggest interesting hypothesis for future research. Unfortunately, we did not assess the apolipoprotein-E genotype (APOε), however this datum is not necessary or itself sufficient for the development of AD [49].

The participants in this investigation were volunteers since it is very difficult to recruit a random sample of elderly person, as in other studies [18, 45, 50].

Finally, we excluded all subjects taking dietary supplements and psychotropic drugs as ascertained from their medical history and physical examination. However, one could argue that the validity and reliability of self-reports of substance use in elderly is questionable. Furthermore, it cannot be excluded that the medications used affect insulin-resistance and, in turn, cognitive performances.

Conclusion

To our knowledge, this is the first time that an association of both the legumes and plant proteins with the cognitive performance has been found in elderly individuals using PCA to obtain food and nutrient patterns. Additional studies are required to assess if the change in the ADAS-cog test obtained in this population after one year would result in a reduced AD risk.

Abbreviations

BMI:

body mass index

WC:

waist circumference

HC:

hip circumference

SBP:

systolic blood pressure

DBP:

diastolic blood pressure

MMSE:

Mini Mental State Examination

ADAS-Cog:

Alzheimer’s disease assessment scale-cognitive sub-scale

PCA:

Principal Components Analysis

References

  1. 1.

    Lourida I, Soni M, Thompson-Coon J, Purandare N, Lang IA, Ukoumunne OC, Llewellyn DJ. Mediterranean diet, cognitive function and dementia: a systematic review. Epidemiology. 2013;24:479–89.

    Article  PubMed  Google Scholar 

  2. 2.

    Ríos JA, Cisternas P, Arrese M, Barja S, Inestrosa NC. Is Alzheimer’s disease related to metabolic syndrome? A Wnt signaling conundrum. Prog Neurobiol. 2014;121:125–46.

    Article  PubMed  Google Scholar 

  3. 3.

    Biessels GJ, Staekenborg S, Brunner E, Brayne C, Scheltens P. Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol. 2006;5:64–74.

    Article  PubMed  Google Scholar 

  4. 4.

    Nurk E, Refsum H, Drevon CA, Tell GS, Nygaard HA, Engedal K, Smith AD. Intake of flavonoid-rich wine, tea and chocolate by elderly men and women is associated with better cognitive test performance. J Nutr. 2009;139:120–7.

    CAS  Article  PubMed  Google Scholar 

  5. 5.

    Codocedo JF, Ríos JA, Godoy JA, Inestrosa NC. Are microRNAs the molecular link between metabolic syndrome and Alzheimer’s disease? Mol Neurobiol. 2016;53:2320–38.

    CAS  Article  PubMed  Google Scholar 

  6. 6.

    Fotuhi M, Mohassel P, Yaffe K. Fish consumption, long-chain omega-3 fatty acids and risk of cognitive decline or Alzheimer disease: a complex association. Nat Clin Pract Neurol. 2009;5:140–52.

    CAS  Article  PubMed  Google Scholar 

  7. 7.

    Barberger-Gateau P, Raffaitin C, Letenneur L, Berr C, Tzourio C, Dartigues JF, Alpérovitch A. Dietary patterns and risk of dementia: the Three-City cohort study. Neurology. 2007;69:1921–30.

    CAS  Article  PubMed  Google Scholar 

  8. 8.

    Féart C, Samieri V, Rondeau H, Amieva F, Portet JF, Dartigues N, Scarmeas N, Barberger-Gateau P. Adherence to a Mediterranean diet, cognitive decline, and risk of dementia. JAMA. 2009;302:638–48.

    Article  PubMed  PubMed Central  Google Scholar 

  9. 9.

    Drewnowski A, Shultz JM. Impact of aging on eating behaviors, food choices, nutrition, and health status. J Nutr Health Aging. 2001;5:75–9.

    CAS  PubMed  Google Scholar 

  10. 10.

    Steenland K, Zhao L, Goldstein F, Cellar J, Lah J. Biomarkers for predicting cognitive decline in those with normal cognition. J Alzheimers Dis. 2014;40:587–94.

    CAS  PubMed  PubMed Central  Google Scholar 

  11. 11.

    Folstein MF, Folstein SE, McHugh PR. “Mini-mental state” a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1995;12:189–98.

    Article  Google Scholar 

  12. 12.

    Plassman BL, Langa KM, Fisher GG, Heeringa SG, Weir DR, Ofstedal MB, Burke JR, Hurd MD, Potter GG, Rodgers WL, Steffens DC, McArdle JJ, Willis RJ, Wallace RB. Prevalence of Cognitive Impairment without Dementia in the United States. Ann Intern Med. 2008;148:427–34.

    Article  PubMed  PubMed Central  Google Scholar 

  13. 13.

    Diniz BS, Yassuda MS, Nunes PV, Radanovic M, Forlenza OV. Mini-mental State Examination performance in mild cognitive impairment subtypes. Int Psychogeriatr. 2007;19:647–56.

    Article  PubMed  Google Scholar 

  14. 14.

    Bianchetti A, Scala V, Cipriani G, Trabucchi M. The Severe Mini Mental State Examination (SMMSE): validation of the Italian version. Res Pract Alzheimer Dis Severe Dement. 2003;8:39–45.

    Google Scholar 

  15. 15.

    Rosen WG, Mohs RC, Davis KL. A new rating scale for Alzheimer’s disease. Am J Psychiatry. 1984;141:1356–64.

    CAS  Article  PubMed  Google Scholar 

  16. 16.

    Peters O, Lorenz D, Fesche A, Schmidtke K, Hüll M, Rüther E, Rüther E, Möller HJ, Jessen F, Maier W, Kornhuber J, Jahn H, Luckhaus C, Gertz HJ, Schröder J, Pantel J, Teipel S, Wellek S, Frölich L, Heuser I. A combination of galantamine and memantine modifies cognitive function in subjects with amnestic MCI. J Nutr Health Aging. 2012;16:544–8.

    CAS  Article  PubMed  Google Scholar 

  17. 17.

    Loy C, Schneider L. Galantamine for Alzheimer’s disease and mild cognitive impairment. Cochrane Database Syst Rev. 2006;1:CD001747.

    Google Scholar 

  18. 18.

    Katzman R, Aronson M, Fuld P, Kawas C, Brown T, Morgenstern H, Frishman W, Gidez L, Eder H, Ooi WL. Development of dementing illnesses in an 80-year-old volunteer cohort. Ann Neurol. 1989;25:317–24.

    CAS  Article  PubMed  Google Scholar 

  19. 19.

    Psaty BM, Furberg CD, Kuller LH, Bild DE, Rautaharju PM, Polak JF, Bovill E, Gottdiener JS. Traditional risk factors and subclinical disease measures as predictors of first myocardial infarction in older adults: the cardiovascular health study. Arch Intern Med. 1999;59:1339–47.

    Article  Google Scholar 

  20. 20.

    Centers for Disease Control and Prevention Tobacco use among adults United States, 2005. MMWR. 2006;55:1145–8.

  21. 21.

    World Medical Association. Declaration of Helsinki. JAMA. 2013;310:2191–4.

    Article  Google Scholar 

  22. 22.

    Pujia A, Gazzaruso C, Ferro Y, Mazza E, Maurotti S, Russo C, Lazzaro V, Romeo S, Montalcini T. Individuals with metabolically healthy overweight/obesity have higher fat utilization than metabolically unhealthy individuals. Nutrients. 2016;8:2. doi:10.3390/nu8010002.

    Article  PubMed Central  Google Scholar 

  23. 23.

    Panagiotakos DB, Pitsavos C, Skoumas Y, Stefanadis C. The association between food patterns and the metabolic syndrome using principal components analysis: the ATTICA Study. J Am Diet Assoc. 2007;107:979–87.

    Article  PubMed  Google Scholar 

  24. 24.

    Ashby-Mitchell K, Peeters A, Anstey KJ. Role of dietary pattern analysis in determining cognitive status in elderly Australian adults. Nutrients. 2015;7:1052–67.

    Article  PubMed  PubMed Central  Google Scholar 

  25. 25.

    Montalcini T, Gorgone G, Fava A, Romeo S, Gazzaruso C, Pujia A. Carotid and brachial arterial enlargement in postmenopausal women with hypertension. Menopause. 2012;19:145–9.

    Article  PubMed  Google Scholar 

  26. 26.

    Montalcini T, Gorgone G, Federico D, Ceravolo R, Emanuele V, Sesti G, Perticone F, Pujia A. Association of LDL cholesterol with carotid atherosclerosis in menopausal women affected by the metabolic syndrome. Nutr Metab Cardiovasc Dis. 2005;15:368–72.

    Article  PubMed  Google Scholar 

  27. 27.

    Montalcini T, Gorgone G, Garzaniti A, Gazzaruso C, Pujia A. Artery remodeling and abdominal adiposity in nonobese postmenopausal women. Eur J Clin Nutr. 2010;64:1022–4.

    CAS  Article  PubMed  Google Scholar 

  28. 28.

    Chrysohoou C, Panagiotakos DB, Pitsavos C, Das UN, Stefanadis C. Adherence to the Mediterranean diet attenuates inflammation and coagulation process in healthy adults: the ATTICA study. J Am Coll Cardiol. 2004;44:152–8.

    Article  PubMed  Google Scholar 

  29. 29.

    Verly-Jr E, Steluti J, Fisberg RM, Marchioni DM. A quantile regression approach can reveal the effect of fruit and vegetable consumption on plasma homocysteine levels. PLoS ONE. 2014;9:e111619.

    Article  PubMed  PubMed Central  Google Scholar 

  30. 30.

    Jacques PF, Bostom AG, Wilson PW, Rich S, Rosenberg IH, Selhub J. Determinants of plasma total homocysteine concentration in the Framingham Offspring cohort. Am J Clin Nutr. 2001;73:613–21.

    CAS  PubMed  Google Scholar 

  31. 31.

    Reilly JG, McTavish SF, Young AH. Rapid depletion of plasma tryptophan: a review of studies and experimental methodology. J Psychopharmacol. 1997;11:381–92.

    CAS  Article  PubMed  Google Scholar 

  32. 32.

    Fernstrom JD, Wurtman RJ. Brain serotonin content: increase following ingestion of carbohydrate diet. Science. 1971;174:1023–5.

    CAS  Article  PubMed  Google Scholar 

  33. 33.

    Markus CR, Panhuysen G, Tuiten A, Koppeschaar H, Fekkes D, Peters ML. Does carbohydrate-rich, protein-poor food prevent a deterioration of mood and cognitive performance of stress-prone subjects when subjected to a stressful task? Appetite. 1998;31:49–65.

    CAS  Article  PubMed  Google Scholar 

  34. 34.

    Schernhammer ES, Feskanich D, Niu C, Dopfel R, Holmes MD, Hankinson SE. Dietary correlates of urinary 6-sulfatoxymelatonin concentrations in the Nurses’ Health Study cohorts. Am J Clin Nutr. 2009;90:975–85.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  35. 35.

    Berti V, Murray J, Davies M, Spector N, Tsui WH, Li Y, Williams S, Pirraglia E, Vallabhajosula S, McHugh P, Pupi A, de Leon MJ, Mosconi L. Nutrient patterns and brain biomarkers of Alzheimer’s disease in cognitively normal individuals. J Nutr Health Aging. 2015;19:413–23.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  36. 36.

    Parrott MD, Shatenstein B, Ferland G, Payette H, Morais JA, Belleville S, Kergoat MJ, Gaudreau P, Greenwood CE. Relationship between diet quality and cognition depends on socioeconomic position in healthy older adults. J Nutr. 2013;143:1767–73.

    CAS  Article  PubMed  Google Scholar 

  37. 37.

    Wengreen H, Munger RG, Cutler A, Quach A, Bowles A, Corcoran C, Tschanz JT, Norton MC, Welsh-Bohmer KA. Prospective study of dietary approaches to stop hypertension—and Mediterranean-style dietary patterns and age-related cognitive change: the Cache County study on memory, health and aging. Am J Clin Nutr. 2013;98:1263–71.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  38. 38.

    Chen X, Huang Y, Cheng HG. Lower intake of vegetables and legumes associated with cognitive decline among illiterate elderly Chinese: a 3-year cohort study. J Nutr Health Aging. 2012;16:549–52.

    CAS  Article  PubMed  Google Scholar 

  39. 39.

    Abete I, Goyenechea E, Zulet MA, Martínez JA. Obesity and metabolic syndrome: potential benefit from specific nutritional components. Nutr Metab Cardiovasc Dis. 2011;21(Suppl 2):B1–15.

    CAS  Article  PubMed  Google Scholar 

  40. 40.

    Mohammad A. The prevention and control the type-2 diabetes by changing lifestyle and dietary pattern. J Educ Health Promot. 2014;3:1.

    Article  Google Scholar 

  41. 41.

    Solerte SB, Fioravanti M, Locatelli E, Bonacasa R, Zamboni M, Basso C, Mazzoleni A, Mansi V, Geroutis N, Gazzaruso C. Improvement of blood glucose control and insulin sensitivity during a long-term (60 weeks) randomized study with amino acid dietary supplements in elderly subjects with type 2 diabetes mellitus. Am J Cardiol. 2008;101:82E–8E.

    CAS  Article  PubMed  Google Scholar 

  42. 42.

    Solerte SB, Gazzaruso C, Bonacasa R, Rondanelli M, Zamboni M, Basso C, Locatelli E, Schifino N, Giustina A, Fioravanti M. Nutritional supplements with oral amino acid mixtures increases whole-body lean mass and insulin sensitivity in elderly subjects with sarcopenia. Am J Cardiol. 2008;101:69E–77E.

    CAS  Article  PubMed  Google Scholar 

  43. 43.

    Ferrand C, Féart C, Martinent G, Albinet C, André N, Audiffren M. Dietary patterns in French home-living older adults: results from the PRAUSE study. Arch Gerontol Geriatr. 2017;70:180–5.

    CAS  Article  PubMed  Google Scholar 

  44. 44.

    Rita Cardoso B, Apolinário D, da Silva Bandeira V, Busse AL, Magaldi RM, Jacob-Filho W, Cozzolino SM. Effects of Brazil nut consumption on selenium status and cognitive performance in older adults with mild cognitive impairment: a randomized controlled pilot trial. Eur J Nutr. 2016;55(107–16):8.

    Google Scholar 

  45. 45.

    Clark CM, Sheppard L, Fillenbaum GG, Galasko D, Morris JC, Koss E, Mohs R, Heyman A. Variability in annual Mini-Mental State Examination score in patients with probable Alzheimer disease: a clinical perspective of data from the Consortium to Establish a Registry for Alzheimer’s Disease. Arch Neurol. 1999;56:857–62.

    CAS  Article  PubMed  Google Scholar 

  46. 46.

    Connor DJ, Sabbagh MN. Administration and scoring variance on the ADAS-Cog. J Alzheimers Dis. 2009;15:461–4.

    Article  Google Scholar 

  47. 47.

    Sutphen CL, Jasielec MS, Shah AR, Macy EM, Xiong C, Vlassenko AG, Benzinger TL, Stoops EE, Vanderstichele HM, Brix B, Darby HD, Vandijck ML, Ladenson JH, Morris JC, Holtzman DM, Fagan AM. Longitudinal cerebrospinal fluid biomarker changes in preclinical Alzheimer disease during middle age. JAMA Neurol. 2015;72:1029–42.

    Article  PubMed  PubMed Central  Google Scholar 

  48. 48.

    O’Bryant SE, Humphreys JD, Smith GE, Ivnik RJ, Graff-Radford NR, Petersen RC, Lucas JA. Detecting dementia with the mini-mental state examination in highly educated individuals. Arch Neurol. 2008;65:963–7.

    PubMed  PubMed Central  Google Scholar 

  49. 49.

    Verghese PB, Castellano JM, Holtzman DM. Apolipoprotein E in Alzheimer’s disease and other neurological disorders. Lancet Neurol. 2011;10:241–52.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  50. 50.

    Herzog AR, Rodgers WL. Age and response rates to interview sample surveys. J Gerontol. 1988;43:S200–5.

    CAS  Article  PubMed  Google Scholar 

Download references

Authors’ contributions

TM and AP were responsible for study design, data analysis, manuscript writing. NB was responsible for neuropsychological assessment and revised nutritional data and manuscript. AF, EM and MM were responsible for data collection and integrity of data. EM, SR, FP were responsible for anthropometric and nutritional measurements, CC and YF were responsible for enrollment and statistical analysis, MG, RT, DF, DR and EG were responsible for laboratory assessment. All authors read and approved the final manuscript.

Acknowledgements

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Availability of data and materials

All data generated or analysed during this study are included in this published article. The data that support the findings of this study are available from Italian Ministry of Health.

Ethics approval and consent to participate

The protocol was approved by the local ethics committee at the “Mater Domini” University Hospital in Catanzaro, Italy (Projects Codes 2011.48).

Funding

This study was supported by a grant from the Italian Ministry of Health (GR 2009-1567179).

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Author information

Affiliations

  1. Department of Clinical and Experimental Medicine, Nutrition Unit, University Magna Grecia, Viale S. Venuta, 88100, Catanzaro, Italy

    Elisa Mazza, Francesco Provenzano & Tiziana Montalcini

  2. Department of Medical and Surgical Science, Nutrition Unit, University Magna Grecia, Catanzaro, Italy

    Antonietta Fava, Yvelise Ferro, Marta Moraca, Stefania Rotundo & Arturo Pujia

  3. Department of Pharmacology, CNR, ISN, University Magna Graecia, Catanzaro, Italy

    Carmela Colica

  4. Department of Health Science, Laboratory Unit, University Magna Grecia, Catanzaro, Italy

    Rosa Terracciano, Marta Greco, Daniela Foti, Elio Gulletta & Diego Russo

  5. Neurology Unit, S. Giovanni di Dio Hospital, Crotone, Italy

    Domenico Bosco

Authors
  1. Elisa Mazza
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Antonietta Fava
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yvelise Ferro
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Marta Moraca
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Stefania Rotundo
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Carmela Colica
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Francesco Provenzano
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Rosa Terracciano
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Marta Greco
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Daniela Foti
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Elio Gulletta
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Diego Russo
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Domenico Bosco
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Arturo Pujia
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. Tiziana Montalcini
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Tiziana Montalcini.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Mazza, E., Fava, A., Ferro, Y. et al. Impact of legumes and plant proteins consumption on cognitive performances in the elderly. J Transl Med 15, 109 (2017). https://doi.org/10.1186/s12967-017-1209-5

Download citation

Keywords

  • Principal Components Analysis
  • Plant protein
  • Legumes
  • Cognitive decline
  • Elderly
  • Mediterranean diet

Journal of Translational Medicine

ISSN: 1479-5876

Contact us